231 related articles for article (PubMed ID: 7779872)
41. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
42. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
Guinet R; Mazoyer MA
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
[TBL] [Abstract][Full Text] [Related]
43. A new method of antibiotyping yeasts for subspecies discrimination and distribution in human clinical specimens.
Quindós G; Lipperheide V; Barturen B; Alonso R; Bikandi J; San Millán R; Tellaetxe M; Ribacoba L; Pontón J
Eur J Epidemiol; 1996 Feb; 12(1):55-62. PubMed ID: 8817179
[TBL] [Abstract][Full Text] [Related]
44. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
[TBL] [Abstract][Full Text] [Related]
45. [Serotyping of 48 isolates of Candida albicans: predominance of serotype A over B in Venezuela].
Mendoza M; Russian E; Villanueva E; de Torres E; de Albornoz MC
Invest Clin; 1992; 33(1):33-7. PubMed ID: 1391075
[TBL] [Abstract][Full Text] [Related]
46. In vitro comparison of the activity of various antifungal drugs against new yeast isolates causing thrush in poultry.
Lin MY; Huang KJ; Kleven SH
Avian Dis; 1989; 33(3):416-21. PubMed ID: 2673187
[TBL] [Abstract][Full Text] [Related]
47. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Gudewicz TM; Mader JT; Davis CP
Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
[TBL] [Abstract][Full Text] [Related]
48. Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
Siikala E; Richardson M; Pfaller MA; Diekema DJ; Messer SA; Perheentupa J; Saxén H; Rautemaa R
Int J Antimicrob Agents; 2009 Dec; 34(6):607-9. PubMed ID: 19748230
[No Abstract] [Full Text] [Related]
49. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
Odds FC; Cheesman SL; Abbott AB
Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
[TBL] [Abstract][Full Text] [Related]
50. Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.
Girish Kumar CP; Hanafy AM; Katsu M; Mikami Y; Menon T
Mycopathologia; 2006 Mar; 161(3):153-9. PubMed ID: 16482387
[TBL] [Abstract][Full Text] [Related]
51. Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses.
Carvalhinho S; Costa AM; Coelho AC; Martins E; Sampaio A
Mycopathologia; 2012 Jul; 174(1):69-76. PubMed ID: 22246961
[TBL] [Abstract][Full Text] [Related]
52. In vitro susceptibility and resistance of Candida spp. to hamycin.
Athar MA
Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
[No Abstract] [Full Text] [Related]
53. Biotypes, genotypes and ketoconazole susceptibility of Candida albicans isolates from a group of Thai AIDS patients.
Teanpaisan R; Niyombandith M; Pripatnanant P; Sattayasanskul W
New Microbiol; 2008 Jul; 31(3):409-16. PubMed ID: 18843897
[TBL] [Abstract][Full Text] [Related]
54. Routine application of the evaluation of yeasts susceptibility to the main antimycotic drugs.
Lombardi G; Cavanna C; Gramegna G; Scevola D; Michelone G
Microbiologica; 1987 Apr; 10(2):189-96. PubMed ID: 3587067
[TBL] [Abstract][Full Text] [Related]
55. [In vitro susceptibility of vaginal Candida albicans to antifungal drugs in Abidjan (Ivory Coast)].
Djohan V; Angora KE; Vanga-Bosson AH; Konaté A; Kassi FK; Yavo W; Kiki-Barro PC; Menan H; Koné M
J Mycol Med; 2012 Jun; 22(2):129-33. PubMed ID: 23518014
[TBL] [Abstract][Full Text] [Related]
56. [In vitro antifungal resistance in Candida albicans from HIV-infected patients with and without oral candidosis.].
Ceballos Salobreña A; Gaitán Cepeda LA; Orihuela Cañada F; Olea Barrionuevo D; Ceballos García L; Quindós G
Rev Iberoam Micol; 1999 Dec; 16(4):194-7. PubMed ID: 18473546
[TBL] [Abstract][Full Text] [Related]
57. [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A].
Corelli F; Massa S; Stefancich G; Mai A; Artico M; Panico S; Simonetti N
Farmaco Sci; 1987 Dec; 42(12):893-903. PubMed ID: 3329612
[TBL] [Abstract][Full Text] [Related]
58. In-vitro activity of antifungal agents in combination with four quinolones.
Petrou MA; Rogers TR
Drugs Exp Clin Res; 1988; 14(1):9-18. PubMed ID: 3292181
[TBL] [Abstract][Full Text] [Related]
59. [Antimycotic susceptibility testing of yeasts important in dermato-venereology: methods, results and clinical relevance].
Korting HC; Georgii A
Hautarzt; 1988 Jun; 39(6):343-7. PubMed ID: 3042703
[TBL] [Abstract][Full Text] [Related]
60. [Characteristics of a strain of C. albicans resistant to polyene antibiotics].
Mikhaĭlova MA; Virina AM; Kravchenko TI
Antibiotiki; 1979 Nov; 24(11):828-31. PubMed ID: 389154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
